Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination.

European journal of radiology - 1 Mar 2010

Czernin Johannes, Benz Matthias R, Allen-Auerbach Martin S

Abstract excerpt

PET/CT with the glucose analogue FDG is emerging as the most important diagnostic imaging tool in oncology. More than 2000 PET/CT scanners are operational worldwide and its unique role for diagnosing, staging, restaging and therapeutic monitoring in cancer is undisputed. Studies conducted in thou...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Contrast Media
Share to Fluorodeoxyglucose F18
Share to Glucose

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycolysis

Share to Neoplasm Staging

Share to Positron-Emission Tomography

Share to Radiopharmaceuticals

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 20097498
DOI: 10.1016/j.ejrad.2009.12.023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20097498-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination.PMID 20097498Read ↗

PET Imaging of Metabolism, Perfusion, and HypoxiaSemantic proximity Read ↗

18[F]FDG-PET/CT is a useful molecular marker in evaluating tumour aggressiveness: a revised understanding of an in-vivo FDG-PET imaging that alludes the alteration of cancer biology.Semantic proximity Read ↗

Molecular PET imaging: Unlocking the secrets of cancer metabolismSemantic proximity Read ↗

Molecular imaging in lymphoma beyond 18F-FDG-PET: understanding the biology and its implications for diagnostics and therapySemantic proximity Read ↗

The FAP-FDG Integration Score (FFIS): Development and prognostic validation of a dual-tracer PET phenotype for solid tumors.Semantic proximity Read ↗

The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.Semantic proximity Read ↗

The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutationsSemantic proximity Read ↗

Diagnostic Value of PET/CT and Maximum Standardized Uptake Value in Patients with Primary LymphomaSemantic proximity Read ↗

The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations.Semantic proximity Read ↗

The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part I)Semantic proximity Read ↗

Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An ¹⁸F-FDG PET Study.Semantic proximity Read ↗

Total Lesion Glycolysis in Positron Emission Tomography Can Predict Gefitinib Outcomes in Non-Small-Cell Lung Cancer with Activating EGFR Mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.